Table 1 The data of demographic and laboratory findings of the AERD and the non-AERD groups are shown

Age (years)

(Min-Max)

40.4 ± 7.70

(31–52)

37.0 ± 8.70

(21–50)

0.35

Previous surgery (%)

N = 3 (27.3%)

N = 3 (30%)

0.98

CT scores

LMS

19.9 ± 3.18

19.4 ± 2.17

0.90

EPOS

5.2 ± 0.79

5.5 ± 0.52

0.90

SNOT

86.6 ± 25.58

81.9 ± 17.35

0.62

Pulmonary function tests

FEV1

Before Salbutamol challenge

After Salbutamol challenge

84.8 ± 12.33

86.9 ± 18.03

75.6 ± 17.85

84.2 ± 15.58

0.20

FEV1/FVC

Before Salbutamol challenge

After Salbutamol challenge

85.6 ± 9.13

86.2 ± 10.04

83.6 ± 7.38

85.7 ± 7.61

0.45

MEF 25–75%

Before Salbutamol challenge

After Salbutamol challenge

81.1 ± 24.41

84.7 ± 25.73

61.0 ± 27.58

78.2 ± 41.30

0.05

Immunoglobulin serum levels

IgG (mg/dL)

941 ± 354

1023 ± 271

0.56

IgM (mg/dL)

158 ± 50

148 ± 64

0.91

IgA (mg/dL)

178 ± 63

176 ± 55

0.70

IgE (IU/mL)

170 ± 96

364 ± 281

0.04

Peripheral blood eosinophil

Percentage (%)

5.3 ± 4.40

5.5 ± 5.40

0.98

Absolute count

390.2 ± 290.20

409.2 ± 436.80

0.91